NIR Hypoxia Imaging of Breast Tumor Response to Neoadjuvant Chemotherapy in Vivo

乳腺肿瘤体内新辅助化疗反应的近红外缺氧成像

基本信息

  • 批准号:
    7739550
  • 负责人:
  • 金额:
    $ 19.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-07-10 至 2011-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Near-infrared (NIR) multi-spectral imaging is a unique tool for characterizing tissue composition in the female breast. The major advantage of this modality is its ability to provide images of tissue oxygen saturation (StO2) as well as total hemoglobin concentration (HbT), water fraction (H2O%) and elastic scattering parameters. Because microcirculation and oxygenation play such major roles in tumor progression and regression, assessing their variation in response to neoadjuvant chemotherapy may reveal early prognostic biomarkers of treatment response that could be used to alter and/or optimize the course of treatment on a more individualized patient basis. Assessing dynamic contrast enhancement in tumor oxygenation after hyperoxic gas inhalation with NIR spectral tomography appears to be feasible and may provide easily- acquired, low cost image signatures for predicting therapeutic response to chemotherapy in the breast. The overall goal of this proposal is to develop and evaluate dynamic NIR tomographic oximetry for characterizing the response of locally advanced breast cancers to neoadjuvant chemotherapy by assessing the temporal variation in tumor oxygenation during hyperoxic gas inhalation. We hypothesize that tumors with initially larger and faster changes before and after breathing 100% oxygen will have better clinical responses to neoadjuvant chemotherapy. This hypothesis will be quantitatively assessed by 1) advancing the current NIR multi-spectral tomography system to image dynamic oxygenation changes within the tumor, induced by breathing 100% oxygen, with a 0.1 Hz image frame rate, 2) quantifying the tumor oxygenation response with respect to hyperoxic inhalation at different times during the course of therapy, and 3) quantifying the pathological and clinical outcomes of response in order to test for correlation with oximetry changes recorded early in the treatment course. Dartmouth College, through the Norris Cotton Cancer Center at the Dartmouth-Hitchcock Medical Center, has significant resources to leverage in order to conduct the proposed study. A group of investigators which includes clinical specialists in diagnostic radiology, surgical oncology, medical oncology, surgical pathology and medical engineering has been configured to develop and evaluate technology for breast imaging for cancer detection, diagnosis and therapy monitoring since 1999. The proposed project is an important component of the research of this group. In addition to the principal investigators, Professor Shudong Jiang and Dr. Peter A. Kaufman, MD, (Medical Oncology), Professors Keith D. Paulsen, Brian W. Pogue and Dr. Wendy A. Wells, MD, (Department of Pathology) will be significant collaborators engaged to accomplish the proposed specific aims, as an adjunct to currently funded grants involving breast imaging research. PUBLIC HEALTH RELEVANCE: This project will develop and evaluate dynamic Near-Infrared (NIR) tomographic oximetry for characterizing the response of locally advanced breast cancers to neoadjuvant chemotherapy by assessing the temporal variation in tumor oxygenation during hyperoxic gas inhalation. NIR oximetry acquired longitudinally during the course of therapy will be correlated with pathological endpoints in order to determine whether early prognostic biomarkers of treatment response can be identified in the dynamic NIR oxygenation signatures that could be used to customize breast cancer treatment decisions to individual patients in the future.
描述(由申请人提供):

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHUDONG JIANG其他文献

SHUDONG JIANG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHUDONG JIANG', 18)}}的其他基金

Concurrent Optical Spectroscopy and Breast MRI to Improve Diagnosis without Contrast Injection
同步光学光谱和乳腺 MRI 无需注射造影剂即可改善诊断
  • 批准号:
    10402775
  • 财政年份:
    2019
  • 资助金额:
    $ 19.96万
  • 项目类别:
Concurrent Optical Spectroscopy and Breast MRI to Improve Diagnosis without Contrast Injection
同步光学光谱和乳腺 MRI 无需注射造影剂即可改善诊断
  • 批准号:
    9816241
  • 财政年份:
    2019
  • 资助金额:
    $ 19.96万
  • 项目类别:
Monitoring Neoadjuvant Chemotherapy Responses with NIR Tomography
使用近红外断层扫描监测新辅助化疗反应
  • 批准号:
    9235258
  • 财政年份:
    2014
  • 资助金额:
    $ 19.96万
  • 项目类别:
Monitoring Neoadjuvant Chemotherapy Responses with NIR Tomography
使用近红外断层扫描监测新辅助化疗反应
  • 批准号:
    8696209
  • 财政年份:
    2014
  • 资助金额:
    $ 19.96万
  • 项目类别:
Pressure-enhanced near-infrared breast cancer imaging
压力增强近红外乳腺癌成像
  • 批准号:
    6870028
  • 财政年份:
    2005
  • 资助金额:
    $ 19.96万
  • 项目类别:
Pressure-enhanced near-infrared breast cancer imaging
压力增强近红外乳腺癌成像
  • 批准号:
    7344778
  • 财政年份:
    2005
  • 资助金额:
    $ 19.96万
  • 项目类别:
Pressure-enhanced near-infrared breast cancer imaging
压力增强近红外乳腺癌成像
  • 批准号:
    7020651
  • 财政年份:
    2005
  • 资助金额:
    $ 19.96万
  • 项目类别:
Pressure-enhanced near-infrared breast cancer imaging
压力增强近红外乳腺癌成像
  • 批准号:
    7189039
  • 财政年份:
    2005
  • 资助金额:
    $ 19.96万
  • 项目类别:

相似海外基金

Shoulder dysfunction and breast cancer treatment: biomechanical analysis of the impact of reconstruction and mastectomy
肩部功能障碍和乳腺癌治疗:重建和乳房切除术影响的生物力学分析
  • 批准号:
    488096
  • 财政年份:
    2023
  • 资助金额:
    $ 19.96万
  • 项目类别:
    Operating Grants
Identification of small molecule inhibitors to exonuclease 1 for breast cancer treatment
鉴定用于乳腺癌治疗的核酸外切酶 1 小分子抑制剂
  • 批准号:
    10735307
  • 财政年份:
    2023
  • 资助金额:
    $ 19.96万
  • 项目类别:
Admin Suppl Gender-affirming estrogen therapy and breast cancer treatment outcome
行政补充性别肯定雌激素治疗和乳腺癌治疗结果
  • 批准号:
    10783533
  • 财政年份:
    2023
  • 资助金额:
    $ 19.96万
  • 项目类别:
Intensive Blood Pressure Control During Cardiotoxic Breast Cancer Treatment (PROTECT) Trial
心脏毒性乳腺癌治疗 (PROTECT) 试验期间强化血压控制
  • 批准号:
    10660289
  • 财政年份:
    2023
  • 资助金额:
    $ 19.96万
  • 项目类别:
Development of Breast Cancer Treatment Strategies Based on Dynamic Changes in Tumor Microenvironment Induced by Drug Modification
基于药物修饰引起的肿瘤微环境动态变化制定乳腺癌治疗策略
  • 批准号:
    23K08035
  • 财政年份:
    2023
  • 资助金额:
    $ 19.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Using a Liquid Biopsy to Optimize Metastatic Breast Cancer Treatment
使用液体活检优化转移性乳腺癌治疗
  • 批准号:
    468409
  • 财政年份:
    2022
  • 资助金额:
    $ 19.96万
  • 项目类别:
    Operating Grants
Improving Adherence to Breast Cancer Treatment Guidelines in Nigeria
提高尼日利亚对乳腺癌治疗指南的遵守率
  • 批准号:
    10684652
  • 财政年份:
    2022
  • 资助金额:
    $ 19.96万
  • 项目类别:
Multifunctional Nanotechnology Platform for Triple Negative Breast Cancer Treatment
用于三阴性乳腺癌治疗的多功能纳米技术平台
  • 批准号:
    10411148
  • 财政年份:
    2022
  • 资助金额:
    $ 19.96万
  • 项目类别:
Multifunctional Nanotechnology Platform for Triple Negative Breast Cancer Treatment
用于三阴性乳腺癌治疗的多功能纳米技术平台
  • 批准号:
    10672232
  • 财政年份:
    2022
  • 资助金额:
    $ 19.96万
  • 项目类别:
Improving Adherence to Breast Cancer Treatment Guidelines in Nigeria
提高尼日利亚对乳腺癌治疗指南的遵守率
  • 批准号:
    10351812
  • 财政年份:
    2022
  • 资助金额:
    $ 19.96万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了